DIASORIN
Research DIASORIN (34D) on Bullrun: dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker34D
- ExchangeDU
- CountryItaly
- CurrencyEUR
- Dividend yield1.7%
- Financial periodFY2025
- RevenueEUR 1.20B
- Revenue growth0.8%
- Net incomeEUR 150.04M
- Free cash flowEUR 281.03M
- Gross margin64.7%
Valuation Snapshot
dividend yield is 1.7%.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.20B | EUR 150.04M | EUR 281.03M | 64.7% | 2.85 | EUR 165.80M | EUR 769.18M | EUR 1.58B |
| FY2024 | EUR 1.19B | EUR 187.06M | EUR 306.66M | 65.9% | 3.35 | EUR 344.27M | n/a | EUR 1.80B |
| FY2023 | EUR 1.15B | EUR 158.51M | EUR 266.20M | 64.6% | 2.87 | EUR 280.31M | n/a | EUR 1.54B |
| FY2022 | EUR 1.36B | EUR 240.11M | EUR 336.15M | 66.2% | 4.15 | EUR 241.78M | n/a | EUR 1.52B |
| FY2021 | EUR 1.24B | EUR 310.73M | EUR 332.19M | 66.6% | 5.4 | EUR 403.02M | n/a | EUR 1.37B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | n/a | n/a | n/a | 0.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 EUR, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.2 EUR |
| FY2024 | 1.15 EUR |
| FY2023 | 1.1 EUR |
| FY2022 | 1.05 EUR |
| FY2021 | 1 EUR |
About DIASORIN
General Information and Consolidation Area General information The Diasorin Group specializes in the development, production, and commercialization of immunodiagnostic and molecular diagnostic tests. The Società Capogruppo Diasorin S.p.A. is headquartered at Via Crescentino snc, Saluggia (VC). The Board of Directors on March 20, 2026, authorized the publication of this Consolidated Financial Statement.
Related stock research
Other related stocks
Frequently asked questions
Does DIASORIN pay a dividend?
DIASORIN has a dividend yield of 1.7%.
What does DIASORIN do?
General Information and Consolidation Area General information The Diasorin Group specializes in the development, production, and commercialization of immunodiagnostic and molecular diagnostic tests. The Società Capogruppo Diasorin S.p.A. is headquartered at Via Crescentino snc, Saluggia (VC). The Board of Directors on March 20, 2026, authorized the publication of this Consolidated Financial Statement.